WO1992002487A1 - Nouveau compose de diamine et agent de protection contre les lesions cerebrales contenant un tel compose - Google Patents
Nouveau compose de diamine et agent de protection contre les lesions cerebrales contenant un tel compose Download PDFInfo
- Publication number
- WO1992002487A1 WO1992002487A1 PCT/JP1990/000970 JP9000970W WO9202487A1 WO 1992002487 A1 WO1992002487 A1 WO 1992002487A1 JP 9000970 W JP9000970 W JP 9000970W WO 9202487 A1 WO9202487 A1 WO 9202487A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- same
- compound
- different
- cerebral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/49—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU9093005056A RU2045522C1 (ru) | 1989-05-30 | 1990-07-30 | Диаминовые соединения или их кислотно-аддитивные соли |
AT90910895T ATE130842T1 (de) | 1989-05-30 | 1990-07-30 | Diaminverbindungen und arzneimittel gegen cerebrale störungen die diese enthalten. |
AU60565/90A AU647034C (en) | 1990-07-30 | Novel diamine compounds and cerebral protective drugs containing the same | |
CA002087604A CA2087604C (en) | 1989-05-30 | 1990-07-30 | Diamine compounds and cerebral protective drugs containing the same |
US07/966,142 US5389630A (en) | 1989-05-30 | 1990-07-30 | Diamine compound and brain protecting agent containing the same |
HU9300228A HU220592B1 (hu) | 1989-05-30 | 1990-07-30 | Eljárás diaminszármazékok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények előállítására |
KR1019930700135A KR0171569B1 (ko) | 1989-05-30 | 1990-07-30 | 신규 디아민 화합물 및 이를 함유하는 뇌보호제 |
ES90910895T ES2081996T3 (es) | 1989-05-30 | 1990-07-30 | Nuevos compuestos de diamina y agentes protectores del cerebro que contienen los mismos. |
DE69023928T DE69023928T2 (de) | 1989-05-30 | 1990-07-30 | DIAMINVERBINDUNGEN UND ARZNEIMITTEL GEGEN CEREBRALE STöRUNGEN DIE DIESE ENTHALTEN. |
EP90910895A EP0541798B1 (en) | 1989-05-30 | 1990-07-30 | New diamine compound and brain protecting agent containing the same |
DK90910895.3T DK0541798T3 (da) | 1989-05-30 | 1990-07-30 | Hidtil ukendt diaminforbindelse og cerebralbeskyttende middel indeholdende denne |
FI930360A FI112649B (fi) | 1989-05-30 | 1993-01-28 | Menetelmä terapeuttisesti käyttökelpoisten diamiiniyhdisteiden valmistamiseksi |
NO930328A NO179322C (no) | 1989-05-30 | 1993-01-29 | Analogifremgangsmåte ved fremstilling av terapeutisk aktive diaminforbindelser |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1136652A JP2722250B2 (ja) | 1989-05-30 | 1989-05-30 | 新規なジアミン化合物及びこれを含有する脳機能障害改善剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992002487A1 true WO1992002487A1 (fr) | 1992-02-20 |
Family
ID=15180337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1990/000970 WO1992002487A1 (fr) | 1989-05-30 | 1990-07-30 | Nouveau compose de diamine et agent de protection contre les lesions cerebrales contenant un tel compose |
Country Status (14)
Country | Link |
---|---|
US (1) | US5389630A (ja) |
EP (1) | EP0541798B1 (ja) |
JP (1) | JP2722250B2 (ja) |
KR (1) | KR0171569B1 (ja) |
AT (1) | ATE130842T1 (ja) |
CA (1) | CA2087604C (ja) |
DE (1) | DE69023928T2 (ja) |
DK (1) | DK0541798T3 (ja) |
ES (1) | ES2081996T3 (ja) |
FI (1) | FI112649B (ja) |
HU (1) | HU220592B1 (ja) |
NO (1) | NO179322C (ja) |
RU (1) | RU2045522C1 (ja) |
WO (1) | WO1992002487A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0623605A2 (de) * | 1993-05-06 | 1994-11-09 | Bayer Ag | Substituierte Piperazine als anti-retrovirale Mittel |
US5514680A (en) * | 1992-06-22 | 1996-05-07 | The State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Glycine receptor antagonists and the use thereof |
US8044078B2 (en) | 2005-09-22 | 2011-10-25 | Sanofi-Aventis | Amino-alkyl amide derivatives as CCR3 receptor ligands |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69426157T2 (de) * | 1993-07-28 | 2001-05-17 | Santen Pharmaceutical Co Ltd | 1,4-di(phenylalkyl)piperazinderivate |
US6017953A (en) * | 1993-12-28 | 2000-01-25 | Allergan Sales, Inc. | Thromboxane ligands |
WO1995019345A1 (fr) * | 1994-01-14 | 1995-07-20 | Nippon Shoji Kabushiki Kaisha | Derive du diazacycloalcanealkylsufonamide |
US5602123A (en) | 1994-11-02 | 1997-02-11 | Kowa Co., Ltd. | Therapeutic agent for myocardial ischemic damages or reperfusion |
US5849737A (en) * | 1995-04-14 | 1998-12-15 | The Regents Of The University Of California | Compositions and methods for treating pain |
US5755237A (en) * | 1995-06-07 | 1998-05-26 | Rodriguez; Victorio C. | Therapeutic use of acetazolamide for the treatment of brain edema |
US5944021A (en) * | 1995-06-07 | 1999-08-31 | Rodriguez; Victorio C. | Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema |
JP3808921B2 (ja) * | 1995-11-20 | 2006-08-16 | 興和株式会社 | 細胞接着阻害剤 |
US6462034B1 (en) | 1998-04-03 | 2002-10-08 | Theravance, Inc. | Local anesthetic compounds and uses |
PE20000354A1 (es) * | 1998-04-03 | 2000-05-20 | Advanced Medicine Inc | Nuevos compuestos y usos anestesicos locales |
SG83735A1 (en) * | 1999-07-03 | 2001-10-16 | Advanced Medicine Inc | Novel local anesthetic compounds and uses |
EP1216243A1 (en) | 1999-10-01 | 2002-06-26 | Advanced Medicine, Inc. | Quinazolinones and analogues and their use as local anesthetics |
US7985751B2 (en) | 2005-08-09 | 2011-07-26 | M's Science Corporation | Piperazine derivatives |
HUP0500886A2 (en) * | 2005-09-23 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use |
HUP0500877A2 (en) * | 2005-09-22 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates |
JP2009508929A (ja) * | 2005-09-22 | 2009-03-05 | サノフイ−アベンテイス | Ccr3受容体リガンドとしてのアミノ−アルキル−アミド誘導体 |
WO2007068754A1 (en) * | 2005-12-16 | 2007-06-21 | Neuropharma, S.A. | Dibenzene derivatives as calcium channel blockers |
ATE486605T1 (de) | 2006-01-27 | 2010-11-15 | Ms Science Corp | Piperidin- und piperazin-derivate |
ATE552833T1 (de) | 2006-02-14 | 2012-04-15 | Eastern Virginia Med School | Methoxypolyethylenglykol-thioester-chelat und dessen verwendung |
JP6026413B2 (ja) * | 2011-06-23 | 2016-11-16 | 学校法人自治医科大学 | プロテアソーム阻害剤 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5732255A (en) * | 1980-08-05 | 1982-02-20 | Kowa Co | Trimethoxyphenyl derivative |
JPS6075469A (ja) * | 1983-06-16 | 1985-04-27 | ベ−リンガ− インゲルハイム リミテツド | 尿素またはチオ尿素化合物 |
JPS60181058A (ja) * | 1984-02-03 | 1985-09-14 | デグツサ・アクチエンゲゼルシヤフト | シアノメチル‐(2‐シアノ‐エチル)‐(3‐ヒドロキシ‐プロピル)‐アミン及びその製法、及び1‐(3‐ヒドロキシ‐プロピル)‐1,4‐ジアゼパン及び1,4‐ビス‐〔3‐(3,4,5‐トリメトキシ‐ベンゾイルオキシ)‐プロピル〕‐ジアゼパンの製法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661481A (en) * | 1983-06-16 | 1987-04-28 | Boehringer Ingelheim Pharmaceuticals, Inc | Substituted phenylalkylhomopiperazinylpropyl(ureas or thioureas) useful for treatment of immulogical, inflammatory and allergic disorders |
JP2556722B2 (ja) * | 1988-02-18 | 1996-11-20 | 興和株式会社 | 新規なスルホンアミド化合物 |
-
1989
- 1989-05-30 JP JP1136652A patent/JP2722250B2/ja not_active Expired - Fee Related
-
1990
- 1990-07-30 EP EP90910895A patent/EP0541798B1/en not_active Expired - Lifetime
- 1990-07-30 WO PCT/JP1990/000970 patent/WO1992002487A1/ja active IP Right Grant
- 1990-07-30 RU RU9093005056A patent/RU2045522C1/ru not_active IP Right Cessation
- 1990-07-30 CA CA002087604A patent/CA2087604C/en not_active Expired - Fee Related
- 1990-07-30 DK DK90910895.3T patent/DK0541798T3/da active
- 1990-07-30 HU HU9300228A patent/HU220592B1/hu not_active IP Right Cessation
- 1990-07-30 AT AT90910895T patent/ATE130842T1/de not_active IP Right Cessation
- 1990-07-30 US US07/966,142 patent/US5389630A/en not_active Expired - Fee Related
- 1990-07-30 ES ES90910895T patent/ES2081996T3/es not_active Expired - Lifetime
- 1990-07-30 DE DE69023928T patent/DE69023928T2/de not_active Expired - Fee Related
- 1990-07-30 KR KR1019930700135A patent/KR0171569B1/ko not_active IP Right Cessation
-
1993
- 1993-01-28 FI FI930360A patent/FI112649B/fi not_active IP Right Cessation
- 1993-01-29 NO NO930328A patent/NO179322C/no unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5732255A (en) * | 1980-08-05 | 1982-02-20 | Kowa Co | Trimethoxyphenyl derivative |
JPS6075469A (ja) * | 1983-06-16 | 1985-04-27 | ベ−リンガ− インゲルハイム リミテツド | 尿素またはチオ尿素化合物 |
JPS60181058A (ja) * | 1984-02-03 | 1985-09-14 | デグツサ・アクチエンゲゼルシヤフト | シアノメチル‐(2‐シアノ‐エチル)‐(3‐ヒドロキシ‐プロピル)‐アミン及びその製法、及び1‐(3‐ヒドロキシ‐プロピル)‐1,4‐ジアゼパン及び1,4‐ビス‐〔3‐(3,4,5‐トリメトキシ‐ベンゾイルオキシ)‐プロピル〕‐ジアゼパンの製法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514680A (en) * | 1992-06-22 | 1996-05-07 | The State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Glycine receptor antagonists and the use thereof |
US5620979A (en) * | 1992-06-22 | 1997-04-15 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Glycine receptor antagonists and the use thereof |
US5622952A (en) * | 1992-06-22 | 1997-04-22 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Glycine receptor antagonists and the use thereof |
EP0623605A2 (de) * | 1993-05-06 | 1994-11-09 | Bayer Ag | Substituierte Piperazine als anti-retrovirale Mittel |
EP0623605A3 (de) * | 1993-05-06 | 1995-03-01 | Bayer Ag | Substituierte Piperazine als anti-retrovirale Mittel. |
US8044078B2 (en) | 2005-09-22 | 2011-10-25 | Sanofi-Aventis | Amino-alkyl amide derivatives as CCR3 receptor ligands |
Also Published As
Publication number | Publication date |
---|---|
FI930360A (fi) | 1993-01-28 |
RU2045522C1 (ru) | 1995-10-10 |
DK0541798T3 (da) | 1995-12-27 |
HUT63143A (en) | 1993-07-28 |
DE69023928T2 (de) | 1996-04-18 |
NO179322B (no) | 1996-06-10 |
HU9300228D0 (en) | 1993-04-28 |
AU647034B2 (en) | 1994-03-17 |
ES2081996T3 (es) | 1996-03-16 |
EP0541798A1 (en) | 1993-05-19 |
ATE130842T1 (de) | 1995-12-15 |
KR0171569B1 (ko) | 1999-05-01 |
AU6056590A (en) | 1992-03-02 |
FI112649B (fi) | 2003-12-31 |
NO930328L (no) | 1993-01-29 |
JPH032144A (ja) | 1991-01-08 |
CA2087604C (en) | 2000-04-18 |
EP0541798A4 (ja) | 1994-04-13 |
FI930360A0 (fi) | 1993-01-28 |
EP0541798B1 (en) | 1995-11-29 |
NO930328D0 (no) | 1993-01-29 |
DE69023928D1 (de) | 1996-01-11 |
US5389630A (en) | 1995-02-14 |
NO179322C (no) | 1996-09-18 |
JP2722250B2 (ja) | 1998-03-04 |
HU220592B1 (hu) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1992002487A1 (fr) | Nouveau compose de diamine et agent de protection contre les lesions cerebrales contenant un tel compose | |
JP3714948B2 (ja) | アミン化合物及びその用途 | |
EP0345808B1 (en) | 1-Indolylalkyl-4-(substituted-pyridinyl)piperazines | |
US7439245B2 (en) | Compounds | |
AU2004209020B2 (en) | New arylpiperazinyl compounds | |
WO2000061556A1 (fr) | Composes heterocycliques contenant de l'azote et composes de benamide et medicaments contenant ces composes | |
JPH04145079A (ja) | インドール誘導体およびその用途 | |
JPH0283375A (ja) | 2−置換ピペラジニル−2−(1,2−ベンズイソキサゾール−3−イル)酢酸誘導体 | |
JP2767321B2 (ja) | ピペラジン誘導体及びこれを含有する医薬 | |
US7375248B2 (en) | Inhibitors of matrix metalloproteinase | |
HU211517A9 (en) | 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them | |
JP2003532616A (ja) | 骨粗鬆症の治療に有用なa.o.インドール誘導体 | |
JPS6047255B2 (ja) | 2−アミノ−5−スルフアモイル−安息香酸アミドの製法 | |
US5472966A (en) | Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines | |
JP2024506715A (ja) | ソマトスタチンモジュレーターの結晶形態 | |
US5212173A (en) | Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them | |
US7476759B2 (en) | Matrix metalloproteinase inhibitors | |
AU698487B2 (en) | Imidazopyridine derivatives | |
WO2023091565A1 (en) | Nsd2-targeted chemical degraders and compositions and methods of use thereof | |
JP2003535845A (ja) | プロパノールアミノテトラリン類、その製造及びそれらを含む組成物 | |
JPS58208270A (ja) | α−環状アミノフエニル酢酸エステル類並びにその酸付加塩類及び第4級アンモニウム塩類 | |
KR19980703590A (ko) | 5-ht1a 수용체에 대한 높은 친화도를 갖는 페녹시에틸아민유도체, 그의 제조, 그의 약물로서의 용도 및 상기 유도체를 함유하는 제약 조성물 | |
JPS62153279A (ja) | 置換フエノキシプロピルアミド誘導体およびその製造法 | |
JPH07242647A (ja) | チアゾリン誘導体 | |
EP0382216A1 (en) | Novel substituted acetamide compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA FI HU KR NO SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1990910895 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2087604 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 930360 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1990910895 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1990910895 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 930360 Country of ref document: FI |